MYB and breast carcinoma: Evidence about Mmp-13 in breast cancer-induced osteolysis indicates this Mmp as a promising therapeutic target for breast cancer bone metastasis (Kwon, 2023), where also Myb is involved as well (Knopfova et al., 2012).